Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Chen, P. Wang, Y. Qi, W. Yao, C. Tang (Beijing, China). Endogenous hydrogen sulfide reduces airway hyperresponsiveness and airway inflammation in a rat model of chronic obstructive pulmonary disease. Eur Respir J 2009; 34: Suppl. 53, 3161

Member's Comments

No comment yet.

Related content which might interest you: Characteristics of airway hyperresponsiveness and reversibility in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Role of tissue kallikrein 1 in late phase bronchoconstriction and airway hyperresponsiveness Source: Annual Congress 2006 - Basic mechanisms of allergic airways inflammation Year: 2006 Association between airway inflammation and systemic inflammation in stable chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 The role of small airways in obstructive airway diseases Source: Eur Respir Rev 2011; 20: 23-33 Year: 2011 Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 640-646 Year: 2005 Cytokine-mediated reactive oxygen species hyperproduction in the airway inflammation of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 178s Year: 2003 Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003 PG6 Assessing and monitoring airway inflammation in asthma andÿchronic obstructive pulmonary disease Source: Milan 2017 - Educational material Year: 2017 Airway inflammation in COPD: physiological outcome measures and induced sputum Source: Eur Respir J 2003; 21: 19S-28S Year: 2003 Relationship between peripheral airway obstruction and airway inflammation in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 509s Year: 2006 Acute protective effect of inhaled fluticasone on airway hyperresponsiveness to adenosine 5’-monophosphate in asthma but not in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 442s Year: 2004 The novel compound Sul-121 inhibits inflammation in experimental models of chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007 Airway pathology in asthma Source: Eur Respir J 2001; 18: 18S-23S Year: 2001 The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Airway remedeling in a mouse model of chronic asthma: relation between the degree of airway remodeling and airway hyperresponsiveness Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004